NeuroMetrix Announces Availability of Quell in Approximately 1,000 Chain Drug Stores

WALTHAM, Mass.-- NeuroMetrix, Inc. (NURO) announced today that Quell® will be available, beginning in June 2016, in approximately 1,000 chain drug stores as part of a retail test with the two largest US drug retailers.

 

"Consumers have told us that they expect to see and purchase Quell at leading chain drug stores," said Shai N. Gozani, M.D., Ph.D., President and CEO of NeuroMetrix. "We are therefore delighted to broaden the availability of Quell, our proprietary, 100% drug free technology for the relief of widespread chronic pain. As Quell represents a new level of technology at premium pricing we will use learning from this test to optimize our full retail expansion.”

 

Quell is FDA cleared and designed for millions of people suffering from chronic pain. Quell gives users the option to start, stop, and adjust therapy discreetly via their smartphone. It also enables advanced sleep tracking that provides feedback on eight dimensions of sleep including sleep duration, quality, body position, time out of bed, and repetitive leg movements throughout the night. Quell is available at select healthcare professionals and retailers. To find a Quell retailer near you, visit the Store Locator at QuellRelief.com.

 

About Quell

 

Quell utilizes NeuroMetrix's patented neurostimulation technology to provide widespread relief from chronic pain. The advanced wearable device is lightweight and can be worn during the day while active, and at night while sleeping. It has been cleared by the FDA for treatment of chronic pain without a prescription. In a recent study, 81% of Quell users reported an improvement in their chronic pain. Quell includes a smartphone app that tracks and personalizes their pain therapy. Quell was recently awarded the Innovation Award at SXSW for best Wearable Technology. It is available for purchase at QuellRelief.com, selected retailers and healthcare professionals.

 

About NeuroMetrix

 

NeuroMetrix is an innovative health-care company that develops wearable medical technology and point-of-care tests that help patients and physicians better manage chronic pain, nerve diseases, and sleep disorders. The company is located in Waltham, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996. For more information, please visit www.NeuroMetrix.com.

 

 

View source version on businesswire.com:http://www.businesswire.com/news/home/20160602005160/en/

 

Contact:

NeuroMetrix, Inc.

Thomas T. Higgins, 781-314-2761

SVP and Chief Financial Officer

This email address is being protected from spambots. You need JavaScript enabled to view it.